We further showed that these behavioral differences are associated with greater changes for ACD in skin thickness, skin perfusion, upregulation of mRNA, and the levels of protein expression of TNF-α, IL-1β, CXCR3, and CXCL10. This evidence concerns the gene CXCR3 and granular corneal dystrophy type II.